Julie Thompson-Dobkin, D.O. — Huntington Beach, California

Julie Thompson-Dobkin, D.O. is a clinical research site located in Huntington Beach, California, United States 92648.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Julie Thompson-Dobkin, D.O. has participated in 3 clinical trials.

Therapeutic areas: Sleep Apnea, Obstructive, Narcolepsy.

Sponsors: Cephalon.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Huntington Beach

Browse all research sites in California · View every site in Huntington Beach

• Hoag Memorial Hospital Presbyterian
• GSK Investigational Site
• Research Site
• Marvel Clinical Research
• Novartis Investigative Site
• City of Hope Seacliff
• Talbert Medical Group
• Novo Nordisk Investigational Site
• Salehi Retina Institute
• Pfizer Investigational Site
• Retina Associates of Southern California
• Pediatric Care Medical Group

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Julie Thompson-Dobkin, D.O.?

Julie Thompson-Dobkin, D.O. has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Julie Thompson-Dobkin, D.O. conducted?

Julie Thompson-Dobkin, D.O. has 3 clinical trials on record. Their work covers Sleep Apnea, Obstructive, Narcolepsy.

Is Julie Thompson-Dobkin, D.O. accredited by Crixeo Clinical Trials?

Julie Thompson-Dobkin, D.O. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Julie Thompson-Dobkin, D.O.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.